Barchi, A.; Mandarino, F.V.; Yacoub, M.-R.; Albarello, L.; Massimino, L.; Savarino, E.V.; Ungaro, F.; Passaretti, S.; Masclee, G.M.C.; Danese, S.;
et al. From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis. Biomolecules 2024, 14, 1080.
https://doi.org/10.3390/biom14091080
AMA Style
Barchi A, Mandarino FV, Yacoub M-R, Albarello L, Massimino L, Savarino EV, Ungaro F, Passaretti S, Masclee GMC, Danese S,
et al. From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis. Biomolecules. 2024; 14(9):1080.
https://doi.org/10.3390/biom14091080
Chicago/Turabian Style
Barchi, Alberto, Francesco Vito Mandarino, Mona-Rita Yacoub, Luca Albarello, Luca Massimino, Edoardo Vincenzo Savarino, Federica Ungaro, Sandro Passaretti, Gwen M. C. Masclee, Silvio Danese,
and et al. 2024. "From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis" Biomolecules 14, no. 9: 1080.
https://doi.org/10.3390/biom14091080
APA Style
Barchi, A., Mandarino, F. V., Yacoub, M.-R., Albarello, L., Massimino, L., Savarino, E. V., Ungaro, F., Passaretti, S., Masclee, G. M. C., Danese, S., Bredenoord, A. J., & Vespa, E.
(2024). From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis. Biomolecules, 14(9), 1080.
https://doi.org/10.3390/biom14091080
